Herpes is one of the most common viral infections in the world, yet it remains widely misunderstood. Caused by the herpes ...

Researchers at the University of Jyväskylä (Finland), in cooperation with national and international research groups, have ...

Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.

Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care ...

The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.

Defects in a single protein involved in cell death may impair the immune system's ability to combat a herpes viral infection in the central nervous system, scientists have found in new research that ...

Herpes researchers at Fred Hutchinson Cancer Research Center have used a gene-editing technique to attack the DNA of the herpes simplex virus in infected mice. This new research is a key step toward a ...

KRAPOSI'S varicelliform eruption is now known to be a clinical syndrome characterized by a virus infection superimposed on a chronic dermatitis, usually an atopic eczema. The responsible virus is ...

Please provide your email address to receive an email when new articles are posted on . The myriad manifestations of herpes simplex keratitis can be difficult to diagnose without a high suspicion, but ...

Herpes simplex virus (HSV1) infections are initiated at mucosal surfaces where the virus infects epithelial cells. When HSV1 spreads from the peripheral nerves and into the central nervous system, it ...

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Herpes Simplex Keratitis Treatment Market Report 2025" report has been added to ResearchAndMarkets.com's offering. The herpes simplex keratitis treatment ...